Juan Carlos Torres, ACNP-BC | |
4100 David Ln, Alexandria, VA 22311-1113 | |
(832) 525-3237 | |
Not Available |
Full Name | Juan Carlos Torres |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 4100 David Ln, Alexandria, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811500754 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0102X | Surgery - Surgical Critical Care | 2020039837 (District Of Columbia) | Secondary |
363L00000X | Nurse Practitioner | 0024180435 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Juan Carlos Torres, ACNP-BC 4100 David Ln, Alexandria, VA 22311-1113 Ph: (832) 525-3237 | Juan Carlos Torres, ACNP-BC 4100 David Ln, Alexandria, VA 22311-1113 Ph: (832) 525-3237 |
News Archive
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure. Their findings are published in the current online issue of the Proceedings of the National Academy of Sciences.
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Joan A. Steitz, Ph.D., a pioneer in the field of RNA biology whose discoveries involved patients with a variety of autoimmune diseases, will be awarded the 2012 Pearl Meister Greengard Prize from The Rockefeller University. The prize, which honors female scientists who have made extraordinary contributions to biomedical science and carries an honorarium of $100,000, will be presented at a ceremony on Thursday, November 29 at Rockefeller University's Caspary Auditorium.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company has developing a long-term, room temperature, storage-stable form of its vaccines. This would replace the current requirement to keep the product frozen at -70o C before use.
› Verified 9 days ago